欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3938/001
药品名称Bortezomib CF 2,5 mg/ml, solution for injection
活性成分
    • Bortezomib 2.5 mg/ml
剂型Solution for injection
上市许可持有人Centrafarm B.V. Breda 4814 NE Nederland
参考成员国 - 产品名称Netherlands (NL)
Bortezomib CF 2,5 mg/ml, oplossing voor injectie
互认成员国 - 产品名称
    • Iceland (IS)
    • Portugal (PT)
    • United Kingdom (Northern Ireland) (XI)
    • Hungary (HU)
      BORTEZOMIB STADA 2,5 mg/ml oldatos injekció
    • Romania (RO)
      Bortezomib Stada 2,5 mg/ml soluţie injectabilă
    • Norway (NO)
    • Cyprus (CY)
      Bortezomib/STADA
    • Estonia (EE)
    • Greece (GR)
    • Latvia (LV)
      Bortezomib Stada 2,5 mg/ml šķīdums injekcijām
    • Malta (MT)
      Bortezomib Clonmel 2.5mg/ml Solution for Injection
    • Germany (DE)
    • Denmark (DK)
      Bortezomib Stada
    • Belgium (BE)
      Bortezomib EG 2,5 mg/ml oplossing voor injectie
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Bortezomib STADA 2,5 mg/ml Injektionslösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Slovakia (SK)
    • Lithuania (LT)
      Bortezomib STADA 2,5 mg/ml injekcinis tirpalas
许可日期2018/01/25
最近更新日期2024/12/24
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase